SKB315 for injection

DRUG2 trials

Sponsors

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.

Conditions

Advanced Solid TumorsGastroesophageal Junction Adenocarcinoma

Phase 1

A Study of SKB315 in Patients With Advanced Solid Tumors

RecruitingNCT05367635

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Advanced Solid Tumors

Start: 2022-03-16End: 2028-06-30Target: 246Updated: 2026-05-08

Phase 2

SKB315 in Combination Therapy in Patients With Advanced or Metastatic GC/ GEJ Adenocarcinoma

Not yet recruitingNCT07609667

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.Gastroesophageal Junction Adenocarcinoma

Start: 2026-06-30End: 2029-06-30Target: 80Updated: 2026-05-27